Animal studies show an important role for the tau protein in a post-ischemic brain injury, suggesting that substances that target different forms of the tau protein have a great potential to reduce the consequences of brain neurodegeneration following cerebral ischemia. The gene discussed is MAPT; the disease is Cerebral ischemia.